Shire To Acquire NPS Pharmaceuticals for $5.2 Billion
This is a 38 percent premium to the average price of NPS stock over the last 45 days and about a 10 percent premium to Friday's close ($41.91).
This acquisition comes after many rumors that Shire was interested.
In June 2014, shares of NPS spiked on a report that Shire was interested in buying the company. NPS stated that it hadn't had any talks with Shire. Rumors heated up once again last month.
On January 5, the Wall Street Journal reported that NPS hired Goldman Sachs to gauge if other companies were interested in an acquisition.
The acquisition comes ahead of NPS' PDUFA decision for Natpara on January 24.
Both companies are scheduled to present at the JP Morgan Healthcare Conference this week.
Many analysts think that Shire may be looking to acquire more companies this year.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.